Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,258,724 papers from all fields of science
Search
Sign In
Create Free Account
bronopol
Known as:
bronopol [Chemical/Ingredient]
, 2-bromo-2-nitropropane-1,3-diol
, 2-bromo-2-nitro-1,3-propanediol
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
20 relations
Allergens
Benzalkonium Chloride 1.15 MG/ML Medicated Pad
Guaifenesin 20 MG/ML Oral Solution
Lactic Acid 18.31 g in 1 L TOPICAL LIQUID [Biocell]
Expand
Broader (4)
Anti-Infective Agents
Anti-Infective Agents, Local
Indicators and Reagents
Propylene Glycols
Narrower (1)
Soft-Tuch
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Personal care product preservatives: risk assessment and mixture toxicities with an industrial wastewater.
J. Carbajo
,
J. A. Perdigón-Melón
,
A. Petre
,
R. Rosal
,
P. Letón
,
E. García-Calvo
Water Research
2015
Corpus ID: 36064886
Highly Cited
2014
Highly Cited
2014
Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to topical preservatives.
Cristin Shaughnessy
,
Dana Malajian
,
D. Belsito
Journal of American Academy of Dermatology
2014
Corpus ID: 205509044
Review
2014
Review
2014
Trends in patch-test results and allergen changes in the standard series: a Mayo Clinic 5-year retrospective review (January 1, 2006, to December 31, 2010).
Ashley B. Wentworth
,
J. Yiannias
,
+13 authors
M. Davis
Journal of American Academy of Dermatology
2014
Corpus ID: 37235790
Highly Cited
2011
Highly Cited
2011
Risk of sensitization to preservatives estimated on the basis of patch test data and exposure, according to a sample of 3541 leave‐on products
A. Schnuch
,
G. Mildau
,
Evamaria Kratz
,
W. Uter
Contact Dermatitis
2011
Corpus ID: 25355616
Background. The risk of sensitization cannot be derived from the frequency of sensitization to allergens alone, but exposure…
Expand
Review
2010
Review
2010
Formaldehyde‐releasers in cosmetics: relationship to formaldehyde contact allergy
A. D. de Groot
,
I. White
,
M. Flyvholm
,
G. Lensen
,
P. Coenraads
Contact Dermatitis
2010
Corpus ID: 29614348
This is the second part of an article on formaldehyde‐releasers in cosmetics. The patch test relationship between the releasers…
Expand
Review
2010
Review
2010
Formaldehyde‐releasers in cosmetics: relationship to formaldehyde contact allergy
A. D. de Groot
,
I. White
,
M. Flyvholm
,
G. Lensen
,
P. Coenraads
Contact Dermatitis
2010
Corpus ID: 39758546
In this part of a series of review articles on formaldehyde‐releasers and their relationship to formaldehyde contact allergy…
Expand
Highly Cited
2010
Highly Cited
2010
An in vitro bacterial adhesion assessment of surface-modified medical-grade PVC.
A. Asadinezhad
,
I. Novák
,
+5 authors
I. Chodák
Colloids and Surfaces B: Biointerfaces
2010
Corpus ID: 847156
2010
2010
Preservatives in cosmetics: reactivity of allergenic formaldehyde‐releasers towards amino acids through breakdown products other than formaldehyde *
Mustapha Kireche
,
E. Giménez-Arnau
,
J. Lepoittevin
Contact Dermatitis
2010
Corpus ID: 35969460
Background: Compounds slowly releasing formaldehyde, the so‐called formaldehyde‐releasers, are commonly employed as preservatives…
Expand
Highly Cited
2006
Highly Cited
2006
Plasma surface modification of poly vinyl chloride for improvement of antibacterial properties.
Wei Zhang
,
P. Chu
,
+5 authors
Qi Yan
Biomaterials
2006
Corpus ID: 36197650
Highly Cited
1988
Highly Cited
1988
Antibacterial action of 2-bromo-2-nitropropane-1,3-diol (bronopol)
Julia A. Shepherd
,
R. Waigh
,
Peter Gilbert
Antimicrobial Agents and Chemotherapy
1988
Corpus ID: 7560376
Patterns of growth inhibition of Escherichia coli in the presence of 2-bromo-2-nitropropane-1,3-diol (bronopol) indicate a period…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE